Effects of an atorvastatin reload on endothelial progenitor cell count and function in patients on chronic statin treatment undergoing PCI

Trial Profile

Effects of an atorvastatin reload on endothelial progenitor cell count and function in patients on chronic statin treatment undergoing PCI

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Sep 2013

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Coronary artery disease
  • Focus Pharmacodynamics
  • Most Recent Events

    • 04 Sep 2013 Results presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.
    • 21 Mar 2013 New trial record
    • 11 Mar 2013 Results presented at the 62nd Annual Scientific Session of the American College of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top